12 April 2018

2 minute read

North America

“Finding the perfect match in parasite control is important for cattlemen everywhere. Wanting fewer parasites is something both cattle and cattlemen can agree on,” said Leona Ferguson, cattle parasiticides and beef franchise marketing manager at Zoetis. “With this in mind, we created this sweepstakes with an entertaining spin on finding the perfect match in parasite control.”

Dectomax^® and Valbazen^® from Zoetis offer time-tested parasite control options for cattlemen, with the following advantages:

• Dectomax Injectable has the broadest coverage of any injectable on the market.
• Dectomax Pour-On has the longest duration of any nonprescription parasite control product, with up to 77 days of activity against the biting cattle louse.
• Valbazen is the only oral drench dewormer that controls Ostertagia ostertagi, liver flukes and Cooperia oncophora, as well as C. punctata.

In the Bovine Match Sweepstakes, participants are invited to upload their photo to find their perfect bovine match from among the cattle images available for selection at the online sweepstakes. Every completed match earns an entry into the 10 weekly drawings for a $100 gift card and the grand prize drawing for a $2,500 gift card. Winners will be randomly selected and personally notified.

Visit BovineMatch.com for more information about the sweepstakes and to learn more about Dectomax and Valbazen.

Dectomax Injectable has a 35-day pre-slaughter withdrawal period. Dectomax Pour-On has a 45-day pre-slaughter withdrawal period. Do not use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. Dectomax has been developed specifically for cattle and swine. Use in dogs may result in fatalities.

Cattle must not be slaughtered within 27 days after the last treatment with Valbazen. Do not use in female dairy cattle of breeding age. Do not administer to female cattle during the first 45 days of pregnancy or for 45 days after removal of bulls.

About Zoetis

Zoetis (NYSE: ZTS) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2017, the company generated annual revenue of $5.3 billion with approximately 9,000 employees. For more information, visit http://www.zoetisUS.com.